240 related articles for article (PubMed ID: 32611697)
1. A Mouse Model for Infection with Enterovirus A71 in Small Extracellular Vesicles.
Gu J; Wu J; Cao Y; Zou X; Jia X; Yin Y; Shen L; Fang D; Mao L
mSphere; 2020 Jul; 5(4):. PubMed ID: 32611697
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.
Lin JY; Weng KF; Chang CK; Gong YN; Huang GJ; Lee HL; Chen YC; Huang CC; Lu JY; Huang PN; Chiang HJ; Chen CM; Shih SR
J Virol; 2021 Oct; 95(21):e0089721. PubMed ID: 34379497
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for the lethal effect of enterovirus A71 intracerebral injection in neonatal mice.
Feng M; Liao Y; Gao Y; Jiang G; Wang L; Zhang Y; Fan S; Xu X; Li Q
Lab Invest; 2020 Apr; 100(4):596-605. PubMed ID: 31857694
[TBL] [Abstract][Full Text] [Related]
4. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
5. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of a Model of Infection by Enterovirus 71 in ICR Mice].
Dong Z; Zhang Z; Yang L; Li D; Shi W
Bing Du Xue Bao; 2016 Nov; 32(6):671-82. PubMed ID: 30004196
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.
Ke Y; Liu WN; Her Z; Liu M; Tan SY; Tan YW; Chan XY; Fan Y; Huang EK; Chen H; En Chang KT; Chan JKY; Hann Chu JJ; Chen Q
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429352
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
9. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence.
Sun L; Tijsma A; Mirabelli C; Baggen J; Wahedi M; Franco D; De Palma A; Leyssen P; Verbeken E; van Kuppeveld FJM; Neyts J; Thibaut HJ
Emerg Microbes Infect; 2019; 8(1):1076-1085. PubMed ID: 31339457
[TBL] [Abstract][Full Text] [Related]
10. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
11. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
12. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
13. Murine models of neonatal susceptibility to a clinical strain of enterovirus A71.
Xie J; Hu X; Li H; Zhu H; Lin W; Li L; Wang J; Song H; Jia L
Virus Res; 2023 Jan; 324():199038. PubMed ID: 36599394
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
15. Global quantitative proteomic analysis profiles of host protein expression in response to enterovirus A71 infection in bronchial epithelial cells based on tandem mass tag (TMT) peptide labeling coupled with LC-MS/MS uncovers the key role of proteasome in virus replication.
Yajie H; Shenglan W; Wei Z; Rufang L; Tingting Y; Yunhui Z; Jie S
Virus Res; 2023 Jun; 330():199118. PubMed ID: 37072100
[TBL] [Abstract][Full Text] [Related]
16. Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route.
Zhu J; Chen N; Zhou S; Zheng K; Sun L; Zhang Y; Cao L; Zhang X; Xiang Q; Chen Z; Wang C; Fan C; He Q
Emerg Microbes Infect; 2018 Dec; 7(1):205. PubMed ID: 30518755
[TBL] [Abstract][Full Text] [Related]
17. Mouse Scarb2 Modulates EV-A71 Pathogenicity in Neonatal Mice.
Miwatashi W; Ishida M; Takashino A; Kobayashi K; Yamaguchi M; Shitara H; Koike S
J Virol; 2022 Aug; 96(15):e0056122. PubMed ID: 35867561
[TBL] [Abstract][Full Text] [Related]
18. A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema.
Victorio CB; Xu Y; Ng Q; Chua BH; Alonso S; Chow VT; Chua KB
Sci Rep; 2016 Jun; 6():28876. PubMed ID: 27357918
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.
Xing J; Wang K; Wang G; Li N; Zhang Y
Arch Virol; 2022 Dec; 167(12):2483-2501. PubMed ID: 36171507
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
